Company / Current Liabilities per Share
Akebia Therapeutics, Inc. Current Liabilities per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.72
FY2025
5-year range
$0.42 / $1.73
FY2021-FY2025
Trend
+74.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share returned to growth in FY2025 after 3 years of decline, reaching $0.72.
Based on SEC 10-K filings.
0.72 in FY2025 with a 10-year CAGR of +2.2%.
Increased from $0.54 to $0.72 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -0.3%
- 5-Year CAGR
- -14.0%
- 10-Year CAGR
- +2.2%
Key checks
Key Insights
- In FY2025, current liabilities per share increased 74.3% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | +74.3% |
| FY2024 | $0.42 | -23.3% |
| FY2023 | $0.54 | -25.9% |
| FY2022 | $0.73 | -57.8% |
| FY2021 | $1.73 | +12.6% |
| FY2020 | $1.54 | -13.6% |
| FY2019 | $1.78 | -68.1% |
| FY2018 | $5.58 | +857.8% |
| FY2015 | $0.58 | -88.3% |
| FY2014 | $4.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026